Literature DB >> 26656886

Potential protective effect of a G>A SNP in the 3'UTR of HLA-A for Chlamydia trachomatis symptomatology and severity of infection.

Marleen E Jansen1, Ivan Branković2, Joke Spaargaren3, Sander Ouburg3, Servaas A Morré4.   

Abstract

The interindividual differences in response to Chlamydia trachomatis (CT) infections are for an important part based on the differences in our host genetic make-up. In the past, several genes and pathways have been identified and linked to protection against or risk for CT infection (i.e. susceptibility), and/or the severity of infection, with a major emphasis on the development of tubal pathology, one of the main causes of female infertility. In the current study, we analyzed in Dutch Caucasian women whether the carriage of HLA-A G>A SNP (rs1655900) was related to the susceptibility of CT infection in a STD cohort (n = 329) and to the severity of infection in a subfertility cohort (n = 482). We also investigated if this A-allele was linked to increase in severity of symptoms, from mild symptoms (lower genital infection) to lower abdominal pain (upper genital tract infection) to the most severe late complication of tubal pathology, including double-sided tubal pathology. We showed that the carriage of HLA-A SNP rs1655900 studied is not associated with the susceptibility to CT infection based on the data from the STD cohort, but might be protective to the development of late complications (p = 0.0349), especially tubal pathology could be relevant. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Chlamydia trachomatis; HLA; SNP; host genetic factors; susceptibility; tubal pathology

Mesh:

Substances:

Year:  2015        PMID: 26656886      PMCID: PMC4857152          DOI: 10.1093/femspd/ftv116

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  25 in total

1.  Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?

Authors:  S A Morré; L Rozendaal; I G van Valkengoed; A J Boeke; P C van Voorst Vader; J Schirm; S de Blok; J A van Den Hoek; G J van Doornum; C J Meijer; A J van Den Brule
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

Review 2.  Conquering sexually transmitted diseases.

Authors:  Michael N Starnbach; Nadia R Roan
Journal:  Nat Rev Immunol       Date:  2008-02-29       Impact factor: 53.106

Review 3.  Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies.

Authors:  William M Geisler
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

4.  CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis.

Authors:  S P Fling; R A Sutherland; L N Steele; B Hess; S E D'Orazio; J Maisonneuve; M F Lampe; P Probst; M N Starnbach
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

Review 5.  Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research.

Authors:  Sam Vasilevsky; Gilbert Greub; Denise Nardelli-Haefliger; David Baud
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

6.  TLR9 KO mice, haplotypes and CPG indices in Chlamydia trachomatis infection.

Authors:  S Ouburg; J M Lyons; J A Land; J E den Hartog; J S A Fennema; H J C de Vries; C A Bruggeman; J I Ito; A S Peña; P S J Lundberg; S A Morré
Journal:  Drugs Today (Barc)       Date:  2009-11       Impact factor: 2.245

Review 7.  Role of CD8(+)T cells in the host response to Chlamydia.

Authors:  Benjamin Wizel; Johanna Nyström-Asklin; Claudio Cortes; Amy Tvinnereim
Journal:  Microbes Infect       Date:  2008-08-26       Impact factor: 2.700

8.  Role of T lymphocytes in the pathogenesis of Chlamydia disease.

Authors:  Joseph U Igietseme; Qing He; Kahaliah Joseph; Francis O Eko; Deborah Lyn; Godwin Ananaba; Angela Campbell; Claudiu Bandea; Carolyn M Black
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

9.  The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology.

Authors:  Sander Ouburg; Joke Spaargaren; Janneke E den Hartog; Jolande A Land; Johan S A Fennema; Jolein Pleijster; A Salvador Peña; Servaas A Morré
Journal:  BMC Infect Dis       Date:  2005-12-20       Impact factor: 3.090

10.  The major CD8 T cell effector memory subset in the normal and Chlamydia trachomatis-infected human endocervix is low in perforin.

Authors:  Joyce A Ibana; Leann Myers; Constance Porretta; Maria Lewis; Stephanie N Taylor; David H Martin; Alison J Quayle
Journal:  BMC Immunol       Date:  2012-12-07       Impact factor: 3.615

View more
  2 in total

1.  The Potential Role for Host Genetic Profiling in Screening for Chlamydia-Associated Tubal Factor Infertility (TFI)-New Perspectives.

Authors:  Jelena Malogajski; Ivan Branković; Jolande A Land; Pierre P M Thomas; Servaas A Morré; Elena Ambrosino
Journal:  Genes (Basel)       Date:  2019-05-28       Impact factor: 4.096

2.  Can Previous Associations of Single Nucleotide Polymorphisms in the TLR2, NOD1, CXCR5, and IL10 Genes in the Susceptibility to and Severity of Chlamydia trachomatis Infections Be Confirmed?

Authors:  Jelmer B Jukema; Bernice M Hoenderboom; Birgit H B van Benthem; Marianne A B van der Sande; Henry J C de Vries; Christian J P A Hoebe; Nicole H T M Dukers-Muijrers; Caroline J Bax; Servaas A Morré; Sander Ouburg
Journal:  Pathogens       Date:  2021-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.